Our data reveal that most CHI patients with diabetes appear to be treated less intense than T1D patients, as significantly more CHI patients with diabetes are treated with conventional insulin therapy, both at diabetes onset and at follow-up. The gene discussed is INS; the disease is diabetes mellitus.